A new double mutant COVID strain has emerged Could it be ready to break loose? nj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nj.com Daily Mail and Mail on Sunday newspapers.
E-Mail
IMAGE: The Hackensack Meridian Health scientists and clinicians continue to study the promise and potential of convalescent plasma for COVID-19 treatment. view more
Credit: Hackensack Meridian Health
March 10, 2021 - Hackensack, NJ - Convalescent plasma, the use of survivors antibodies transfused into sick COVID-19 patients is safe and significantly improves clinical outcomes when using high levels of antibodies, according to a new publication by scientists at Hackensack Meridian Health, New Jersey s largest and most comprehensive health network.
The treatment was safe, transferred the survivors antibodies, and did not prevent the recipients from making their own antibodies, according to the results published recently in the journal
Hackensack Meridian Health establishes Hackensack Meridian Health Foundation
Hackensack Meridian Health establishes Hackensack Meridian Health Foundation
Hackensack Meridian Health announced the formation of Hackensack Meridian Health Foundation.
The newly created foundation will serve as the parent organization for the networkâs 10 community-based hospital foundations.
In addition to raising funds for the networkâs local medical centers, Hackensack Meridian Health Foundation will also focus on network-wide priorities such as behavioral health, childrenâs health, the Hackensack Meridian Center for Discovery & Innovation and the Hackensack Meridian School of Medicine, according to information provided by Hackensack Meridian Health.
âThe establishment of one network-wide philanthropic entity has been a goal for a long time,â Robert C. Garrett, FACHE, chief executive officer of Hackensack Meridian Health, said in the st
A new test developed by New Jersey s largest hospital network to detect COVID-19 variants may help public health officials understand how widespread the mutations are and how much they are contributing to a recent surge in cases and hospitalizations, scientists announced Thursday.
The test developed at Hackensack Meridian Center for Discovery and Innovation in Nutley can identify the United Kingdom, Brazilian, and South African variants in about 2½ hours. That is significantly faster than genomic sequencing, which takes one to three days to complete. The laboratory is processing about 100 samples every few hours.
Like the rest of the U.S., New Jersey has been flying blind about the variants presence because it lacks the lab capacity to do the complex, labor-intensive testing on a large scale.
Advanced Test Developed to Track and Diagnose COVID-19 Variants - New Jersey Business Magazine njbmagazine.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from njbmagazine.com Daily Mail and Mail on Sunday newspapers.